Exane Derivatives’s Unilever NV New York Registry Shares UN Stock Holding History
Bought
Maintained
Sold
Other funds holding UN
GRQ
BBHC
SCCM
Exane Derivatives's UN Position: Q2 2019 in Review
Exane Derivatives sold out of Unilever NV New York Registry Shares (UN) in Q2 2019, closing a stake of 44,134 shares — an estimated $2.57M sold.
Exane Derivatives first reported a position in UN in Q1 2018 and held it in 5 quarters. The position peaked at $2.66M in Q4 2018. 603 funds tracked by Wall St. Rank hold UN as of Q2 2019.
- Exane Derivatives reported no remaining Unilever NV New York Registry Shares position as of Q2 2019 after selling out during the quarter.
- Exane Derivatives sold 44,134 Unilever NV New York Registry Shares shares in Q2 2019, an estimated $2.57M.
- Exane Derivatives first reported a position in Unilever NV New York Registry Shares in Q1 2018 and held it in 5 quarters.
- Exane Derivatives's Unilever NV New York Registry Shares position peaked at $2.66M in Q4 2018.
- 603 funds tracked by Wall St. Rank held Unilever NV New York Registry Shares as of Q2 2019.
Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.